Panzyga

Pfizer Laboratories Div Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: May 8, 2025
Approval ID: e2cc5ddf-119e-ade3-79c2-c712cfbee099
Products: 6 registered
Version: 9

Regulatory Information

Labeling Type

PLASMA DERIVATIVE

Status

Approved

Full Title

These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 2018

Quick Stats

Total Products6

Labelers2

Label Sections40

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.